Compound Summary
Compound Name: | 			73285-50-4 | 
Compound CID: | 			13018787 | 
Synonyms: | 			73285-50-4 Duvoglustat hydrochloride 1-Deoxynojirimycin hydrochloride Deoxynojirimycin hydrochloride Duvoglustat HCl More... | 
Iupac Name: | 			(2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride | 
InChI: | 					InChI=1S/C6H13NO4.ClH/c8-2-3-5(10)6(11)4(9)1-7-3;/h3-11H,1-2H2;1H/t3-,4+,5-,6-;/m1./s1 | 
InChIKey: | 				ZJIHMALTJRDNQI-VFQQELCFSA-N | 
Canonical Smiles: | 		C1C(C(C(C(N1)CO)O)O)O.Cl | 
Isomeric Smiles: | 			C1[C@@H]([C@H]([C@@H]([C@H](N1)CO)O)O)O.Cl | 
Molecular Weight: | 		199.63 | 
Molecular Formula: | 			C6H14ClNO4 | 
Molecular Weight: | 		199.63 | 
Molecular Formula: | 			C6H14ClNO4 | 
Hydrogen Bond Donor Count: | 			6 | 
Hydrogen Bond Acceptor Count: | 			5 | 
Rotatable Bond Count: | 			1 | 
Heavy Atom Count: | 					12 | 
Complexity: | 				132 | 
| 73285-50-4 | 73285-50-4 | 
|---|---|
73285-50-4 | 			
Duvoglustat hydrochloride | 
1-Deoxynojirimycin hydrochloride | 			
Deoxynojirimycin hydrochloride | 
Duvoglustat HCl | 			
1-Deoxy-L-altronojirimycin Hydrochloride | 
(2R,3R,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol hydrochloride | 			
UNII-0RN23C42QR | 
AT2220 | 			
355138-93-1 | 
AT 2220 | 			
AT-2220 | 
0RN23C42QR | 			
Duvoglustat hydrochloride USAN | 
(2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride | 			
73285-50-4 (HCL) | 
Duvoglustat hydrochloride (USAN) | 			
Moranoline HCl | 
BAY-h-5595 | 			
1-Deoxynojirimycin (hydrochloride) | 
Moranoline hydrochloride | 			
DNJ | 
Deoxynojirimycin HCl | 			
Moranolin hydrochloride | 
1,5-Dideoxy-1,5-imino-D-sorbitol hydrochloride | 			
DNJAT2220 | 
CHEMBL460785 | 			
SCHEMBL1320203 | 
DTXSID401017351 | 			
HGT-3510 | 
HY-14860A | 			
MFCD00133247 | 
AKOS030253224 | 			
AS-60890 | 
SC-48305 | 			
CS-0101849 | 
D09606 | 			
F19165 | 
732D504 | 			
Q27237146 | 
3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)- | 			
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -2.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | -2.000000000000000 | 1 | 1 |